Autism

Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism
ASD is characterized by deficits in sociability, sensory processing and by stereotypical behaviors. Animals prenatally exposed to VPA showed purinergic-related molecular alterations. Suramin rescued ASD-like impairments in the VPA-animal model.